What are the treatment guidelines for kidney stones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Guidelines for Kidney Stones

Acute Pain Management

NSAIDs are the first-line treatment for acute renal colic pain, superior to opioids in efficacy with fewer side effects. 1

  • Diclofenac, ibuprofen, or metamizole should be used at the lowest effective dose to minimize cardiovascular and gastrointestinal risks 1
  • Exercise caution with NSAIDs in patients with reduced glomerular filtration rate as they may impact renal function 1
  • Opioids (hydromorphine, pentazocine, or tramadol) should be reserved as second-line agents when NSAIDs are contraindicated or ineffective 2, 1
  • Avoid pethidine due to high vomiting rates 1

Conservative Management vs. Surgical Intervention

Ureteral Stones ≤10 mm

For uncomplicated ureteral stones ≤10 mm, observation with medical expulsive therapy using alpha-blockers is the recommended first-line approach. 2, 1

  • Alpha-blockers (tamsulosin) provide the greatest benefit for stones >5 mm in the distal ureter, with stone-free rates of 77.3% compared to 54.4% with placebo (OR 3.79,95% CI 2.84-5.06) 2
  • Conservative management requires well-controlled pain, absence of sepsis, and adequate renal functional reserve 1
  • Maximum duration of conservative treatment should be 4-6 weeks from initial presentation 3, 1
  • Mandatory periodic imaging is required to monitor stone position and assess for hydronephrosis 1

Ureteral Stones >10 mm

  • For distal ureteral stones >10 mm, ureteroscopy (URS) is the first-line surgical treatment 1
  • For distal stones <10 mm that fail conservative management, both ureteroscopy and shock wave lithotripsy (SWL) are acceptable options 1

Surgical Management of Renal Stones

Renal Stones <10 mm

For renal stones <10 mm regardless of location, ureteroscopy or shock wave lithotripsy are recommended first-line options. 2, 4

  • Spontaneous passage rates are 75% for stones <5 mm and 62% for stones ≥5 mm 4
  • For asymptomatic, non-obstructing caliceal stones up to 15 mm, active surveillance is a viable option 4

Renal Stones 10-20 mm

For non-lower pole renal stones 10-20 mm, both shock wave lithotripsy and ureteroscopy are acceptable first-line treatments. 4

  • URS is associated with higher single-procedure stone-free rates but has slightly higher complication rates 4
  • For lower pole stones 10-20 mm, ureteroscopy or percutaneous nephrolithotomy (PCNL) are recommended 2
  • SWL is acceptable for lower pole stones 10-20 mm only with favorable conditions (broad infundibulo-pelvic angle, short infundibulum, short skin-to-stone distance, wide infundibulum, or shockwave favorable stone composition) 2

Renal Stones >20 mm

For renal stones >20 mm regardless of location, percutaneous nephrolithotomy should be offered as first-line therapy. 2, 4

  • PCNL offers higher stone-free rates (94% vs. 75% for URS) and is less dependent on stone composition, density, and location 4
  • SWL is not recommended for stones >20 mm or for cystine staghorn calculi 4
  • PCNL complications include fever (10.8%), transfusion (7%), thoracic complications (1.5%), and sepsis (0.5%) 4

Procedural Considerations

Shock Wave Lithotripsy (SWL)

  • Routine pre-stenting is not recommended before SWL as it provides no benefit and causes frequent stent-related symptoms 2, 4, 1
  • Alpha-blockers may be prescribed after SWL to facilitate passage of stone fragments 4
  • SWL complications include fever (10.8%), need for transfusion (7%), and sepsis (0.5%) 4

Ureteroscopy (URS)

  • A safety wire is required during the procedure 4
  • Laser or pneumatic lithotripsy may be used with semi-rigid ureteroscopes, while laser lithotripsy is preferred for flexible URS 4
  • Routine stent placement is not recommended after uncomplicated URS 2, 4
  • Alpha-blockers and anti-muscarinics may be prescribed to reduce stent discomfort if stenting is required 4
  • For patients on antithrombotic therapy that cannot be discontinued, flexible URS is recommended 4

Percutaneous Nephrolithotomy (PCNL)

  • Noncontrast CT is recommended prior to performing PCNL 2
  • Tubeless PCNL (no nephrostomy tube) or totally tubeless (without nephrostomy tube or ureteral stent) can be considered in uncomplicated cases to reduce pain and hospital stay 2, 4

Emergency Situations Requiring Urgent Intervention

In cases of obstructing stones with suspected infection and sepsis, urgent drainage of the collecting system with a ureteral stent or nephrostomy tube is mandatory before definitive stone treatment. 4, 1

  • Delay definitive stone treatment until sepsis is resolved 1
  • Collect urine for antibiogram testing before and after decompression 1
  • Administer antibiotics immediately and adjust based on culture results 1
  • Urinalysis and/or urine culture should be obtained prior to surgical intervention to rule out urinary tract infection 2

Medical Management for Stone Prevention

Calcium Stones

  • Thiazide diuretics should be offered to patients with high or relatively high urine calcium and recurrent calcium stones 3
  • Potassium citrate therapy should be offered to patients with recurrent calcium stones and low or relatively low urinary citrate 3

Uric Acid Stones

For uric acid stones, oral chemolysis with alkalinization using potassium citrate or sodium bicarbonate is strongly recommended as first-line therapy, with a target pH 7.0-7.2. 3, 1

  • The success rate of oral chemolysis is approximately 80.5%, with 15.7% requiring further intervention 1
  • Patients should monitor urine pH and adjust medication accordingly 1

Cystine Stones

  • First-line therapy includes increased fluid intake, restriction of sodium and protein intake, and urinary alkalinization 3

Brushite Stones

  • Potassium citrate is first-line pharmacological therapy for brushite stone formers with hypocitraturia or elevated urine pH 3
  • Thiazide diuretics should be offered to brushite stone formers with hypercalciuria 3

Preoperative Evaluation

  • Obtain detailed medical and dietary history to identify conditions, habits, or medications that may predispose to stone disease 3
  • Serum chemistries including electrolytes, calcium, creatinine, and uric acid should be ordered 3
  • Urinalysis including dipstick and microscopic evaluation should be performed to assess urine pH, indicators of infection, and identify crystals 3
  • Renal ultrasonography is the recommended first-line imaging modality 3, 5
  • Noncontrast CT is helpful to determine the optimal surgical intervention 2

Follow-up and Monitoring

  • A single 24-hour urine specimen for stone risk factors should be obtained within six months of initiating treatment to assess response to dietary and/or medical therapy 3
  • After initial follow-up, a single 24-hour urine specimen should be obtained annually or with greater frequency, depending on stone activity 3
  • Periodic blood testing should be performed to assess for adverse effects in patients on pharmacological therapy 3
  • Follow-up imaging is recommended to monitor for stone growth, which would indicate the need for intervention 4

Common Pitfalls to Avoid

  • Do not offer prolonged conservative management beyond 4-6 weeks without reassessment 1
  • Do not use routine stenting before shock wave lithotripsy 1
  • Avoid using NSAIDs in patients with significantly reduced renal function without careful monitoring 1
  • Do not neglect to address underlying metabolic abnormalities that contribute to stone formation 3
  • Do not prescribe allopurinol as first-line therapy for uric acid stones instead of urinary alkalinization with potassium citrate 3
  • Nephrectomy may be considered when the involved kidney has negligible function 4

References

Guideline

First-Line Treatment of Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Kidney Stone Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Options for Renal Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kidney Disease: Kidney Stones.

FP essentials, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.